Get access

Inactivation of DNA Mismatch Repair by Variants of Uncertain Significance in the PMS2 Gene


  • Contract grant sponsor: NIH (1R01CA164944-01A1).

  • Communicated by Rolf H. Sijmons


Lynch syndrome (LS) is a common cancer predisposition caused by an inactivating mutation in one of four DNA mismatch repair (MMR) genes. Frequently a variant of uncertain significance (VUS), rather than an obviously pathogenic mutation, is identified in one of these genes. The inability to define pathogenicity of such variants precludes targeted healthcare. Here, we have modified a cell-free assay to test VUS in the MMR gene PMS2 for functional activity. We have analyzed nearly all VUS in PMS2 found thus far and describe loss of MMR activity for five, suggesting the applicability of the assay for diagnosis of LS.

Get access to the full text of this article